FDA approves Agios Pharmaceuticals’ Tibsovo for acute myeloid leukemia
The approval is the latest of several drugs approved for the disease, a form of blood cancer, since last year.
Agios: You may not have to kill cancer to conquer it
Killing cancer cells isn’t the only way to keep the disease at bay, researchers are learning: Coaxing immature, ill-developed cancer cells to return to their normal function is an alternate approach to controlling malignancies. It’s described nicely in a piece by New Yorker staffer and Harvard medicine chair Jerome Groopman: The Transformation – Is it possible to control cancer without […]
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.